<DOC>
	<DOCNO>NCT02596022</DOCNO>
	<brief_summary>Repeated drug consumption may progress problematic use trigger neuroplastic adaptation attenuate sensitivity natural reward increase reactivity crave drug cue . Converging evidence suggest glutamate modulation may work correct adaptation rapidly restore motivation delay non-drug reward relative immediate drug use . Using establish laboratory model aim evaluate behavioral shift salience cocaine vs. money later , investigator test effect CI-581a cocaine self-administration compare active control .</brief_summary>
	<brief_title>The Effect Glutamatergic Modulation Cocaine Self-administration</brief_title>
	<detailed_description />
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>1 . Active cocaine dependence least 8 day use least 4 binge large amount ( &gt; $ 200/occasion ) past 30 day , display least one positive utox screen 2 . Physically healthy 3 . No adverse reaction study medication 4 . 2155 year age 5 . Capacity consent comply study procedure , include sufficient proficiency English 6 . Not seek treatment 1 . Meets DSM IV criterion current major depression , bipolar disorder , schizophrenia , psychotic illness , include substance induce psychosis , current substanceinduced mood disorder HAMD score &gt; 12 . 2 . Physiological dependence another substance , alcohol , opioids , benzodiazepine , exclude caffeine , nicotine , cannabis 3 . Delirium , Dementia , Amnesia , Cognitive Disorders , Dissociative disorder 4 . Current suicide risk history suicide attempt within past year 5 . Pregnant interested become pregnant study period 6 . Any following cardiac condition : clinically significant leave ventricular hypertrophy , angina , clinically significant arrhythmia , mitral valve prolapse 7 . Unstable physical disorder might make participation hazardous endstage AIDS , hypertension ( &gt; 140/90 ) , WBC &lt; 3.5 , active hepatitis liver disease elevate transaminase level ( &lt; 23 X upper limit normal consider acceptable PT/PTT normal ) , renal failure ( creat &gt; 2 , BUN &gt; 40 ) , untreated diabetes 8 . Previous history ketamine midazolam misuse abuse , history adverse reaction/experience prior exposure cocaine , ketamine midazolam 9 . Recent history significant violence ( past 2 year ) 10 . Abnormal pseudocholinesterase level 11 . First degree relative psychotic disorder ( bipolar disorder , schizophrenia , schizoaffective disorder , psychosis NOS ) 12 . BMI &gt; 35 , history document obstructive sleep apnea 13 . On psychotropic medication whose effect could disrupt participation study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>